Clinical Summary: Nalsign 50 Mg widely prescribed in addiction medicine and primary care as Nalsign 50 or nalsign 50 mg tablet is a prescription oral opioid receptor antagonist manufactured by HAB Pharmaceuticals & Research Ltd., formulated with Naltrexone Hydrochloride IP 50 mg per tablet. Clinically bioequivalent to reference brands such as ReVia 50 mg and Australian domestic equivalents (ARX-Naltrexone 50 mg), Nalsign 50 Mg is clinically indicated as part of a comprehensive recovery program for alcohol dependence (Alcohol Use Disorder) and relapse prevention in detoxified, formerly opioid-dependent adults. Unlike opioid substitution medications, Nalsign 50 is completely non-addictive, produces no euphoria, and works by blocking brain opioid receptors to reduce alcohol cravings and prevent the rewarding effects of alcohol or opioids.
Product Specifications
| Clinical & Commercial Parameter | Product Formulation Details |
| Product Trade Name | Nalsign 50 Mg / Nalsign 50 / Nalsign 50 mg Tablet |
| Active Pharmaceutical Ingredient (API) | Naltrexone Hydrochloride IP (50 mg per oral tablet) |
| Reference Innovator Brands | ReVia 50 mg (Teva/Duramed), ARX-Naltrexone 50 mg (Australia) |
| Pharmacological Class | Pure Competitive Opioid Receptor Antagonist (-Opioid Blocker) |
| Dosage Format & Packaging | Oral tablet; blister strip of 10 tablets (10 x 10 box = 100 tablets) |
| Primary Clinical Indications | Alcohol Use Disorder (Alcohol Dependence) & Opioid Relapse Prevention |
| Standard Maintenance Dosage | 50 mg once daily (taken with or without food) |
| Elimination Half-Life () | 4 hours (parent naltrexone) / 13 hours (active 6–naltrexol metabolite) |
| Duration of Receptor Blockade | 24 to 72 hours per 50 mg dose |
| Storage Conditions | Store below 25°C in a dry place; protect from light and moisture |
| Australian Regulatory Schedule | Schedule 4 (S4) – Prescription Only Medicine |
What is Nalsign 50 Mg (Naltrexone Hydrochloride)?
Nalsign 50 Mg is a daily oral medication engineered to support long-term abstinence and relapse prevention in alcohol and opioid recovery.
Unlike substitution medications such as methadone or buprenorphine which activate opioid receptors partially or fully Nalsign 50 is a pure opioid antagonist. It attaches tightly to opioid receptors in the brain without activating them, acting like a protective shield that blocks both natural endorphins triggered by alcohol and external opioid drugs. Because it has zero narcotic activity, Nalsign 50 Mg is not habit-forming, cannot be abused, and does not cause withdrawal symptoms when discontinued.
What is Nalsign 50 Mg Used For? (nalsign 50 mg uses)
Addiction specialists, psychiatrists, and general practitioners prescribe nalsign 50 mg uses across two primary clinical indications:
- Alcohol Dependence (Alcohol Use Disorder): Used alongside counseling, behavioral therapy, and peer support to reduce obsessive alcohol cravings, eliminate the rewarding “buzz” of drinking, lower total heavy-drinking days, and help patients maintain sobriety. (Note: Unlike disulfiram, Nalsign 50 does not cause violent nausea/flushing if alcohol is consumed instead, it removes the pleasurable reinforcement of drinking).
- Opioid Dependence Relapse Prevention: Prescribed as maintenance therapy for detoxified, formerly opioid-dependent individuals (such as those recovering from heroin, oxycodone, morphine, or codeine dependence) who have remained completely opioid-free for at least 7 to 10 days, blocking the euphoric high if a slip occurs.
Mechanism of Action: How Nalsign 50 Blocks Cravings and Euphoria
Nalsign 50 mg tablet interrupts neurochemical reward loops in the brain without causing sedation or intoxication:
- Competitive -Opioid Receptor Blockade: Naltrexone and its long-acting active metabolite (6--naltrexol) bind competitively to central nervous system mu ()-opioid receptors.
- Blunting Alcohol’s Endorphin Reward: Drinking alcohol stimulates the brain to release natural endorphins that trigger dopamine reward signals. By blocking -opioid receptors, Nalsign 50 Mg dampens that dopamine surge, steadily reducing cravings and breaking the psychological reward cycle of alcohol.
- Preventing External Opioid Binding: If a patient takes heroin or a prescription opioid while on Nalsign 50, the drug is physically blocked from binding to brain receptors, preventing euphoria and sedation.
Nalsign 50 Mg Dosage & Administration Guidelines
Following strict initiation and dosing rules is essential for safety and treatment success:
| Clinical Indication | Initiation Protocol | Standard Maintenance Dose | Recommended Treatment Duration |
| Alcohol Dependence | 25 mg once daily for Days 1–3 (to minimize initial nausea), then increase to 50 mg once daily | 50 mg once daily | Typically 3 to 6 months (up to 12 months or longer as advised by your doctor) |
| Opioid Relapse Prevention | Must be opioid-free for 7–10 days first. Start with 25 mg on Day 1; if no withdrawal occurs, increase to 50 mg once daily | 50 mg once daily (or supervised alternate-day schedules such as 100 mg Mon/Wed, 150 mg Fri) | Individualized under specialist addiction care |
Practical Administration Rules
- With or Without Food: Swallow Nalsign 50 Mg whole with a full glass of water at the same time each day, with or without meals. Taking the tablet with food during the first week helps prevent mild stomach upset.
- Missed Dose Rule: Take a missed dose as soon as you remember. If it is close to your next scheduled daily dose, skip the missed tablet and resume your regular schedule. Never take two tablets together.
CRITICAL SAFETY WARNINGS: Precipitated Withdrawal & Overdose Risk
Before taking Nalsign 50 Mg, patients and caregivers must understand three life-saving safety rules:
1. Mandatory 7- to 10-Day Opioid-Free Period (Precipitated Withdrawal Warning)
NEVER take Nalsign 50 Mg if you have used any opioid within the past 7 to 10 days (or within 10–14 days for long-acting opioids like methadone or buprenorphine). Because Nalsign 50 forcibly knocks opioids off brain receptors within minutes, taking it while opioids are still in your body triggers severe, acute precipitated opioid withdrawal causing intense vomiting, diarrhea, sweating, extreme agitation, rapid heart rate, and confusion that may require emergency hospitalization. Doctors verify abstinence via urine drug screening (and occasionally a naloxone challenge test) before starting therapy.
2. High Risk of Fatal Overdose After Stopping Nalsign 50
While taking Nalsign 50 Mg, your body’s natural tolerance to opioids drops dramatically. If you stop taking Nalsign 50 and return to using your previous dose of heroin or prescription opioids, that dose can overwhelm your respiratory system and cause fatal overdose. Never attempt to “override” Nalsign 50 by taking large amounts of opioids doing so can cause coma and respiratory arrest as naltrexone wears off.
3. Blockade of Opioid Painkillers & Emergency Medical Alert
- Avoid All Opioid Medicines: Nalsign 50 blocks the effects of opioid pain relievers (codeine, tramadol, oxycodone, morphine, fentanyl), opioid cough suppressants, and opioid anti-diarrheal medicines. Use non-opioid pain relievers (such as paracetamol or NSAIDs, if approved by your doctor) for everyday aches.
- Carry a Medical Alert Card: Carry a wallet card or wear medical identification stating “I am taking Naltrexone (Nalsign 50 mg) – Opioid Analgesics Will Be Blocked” so emergency doctors can provide alternative non-opioid regional or general anesthesia if you are injured or need urgent surgery.
Side Effects & Liver Function Monitoring
Nalsign 50 Mg is generally well tolerated once the body adjusts during the first week:
1. Common, Manageable Side Effects
- Gastrointestinal (Most Common in Week 1): Mild nausea (~10%), abdominal cramping, vomiting, loss of appetite, or diarrhea/constipation (usually subsides within 5 to 7 days).
- Nervous System & Energy: Headache (~7%), dizziness, fatigue, nervousness, anxiety, or difficulty sleeping (insomnia).
- Musculoskeletal: Mild joint or muscle aches.
2. Liver Health Monitoring (Hepatotoxicity Warning)
High doses of naltrexone can cause liver enzyme elevations. Nalsign 50 Mg is contraindicated in patients with acute hepatitis or liver failure. Your doctor will order baseline liver function blood tests (LFTs) before starting treatment and repeat them periodically. Stop taking Nalsign 50 and contact your doctor immediately if you notice persistent right-sided upper abdominal pain, dark tea-colored urine, pale stools, unusual fatigue, or yellowing of the eyes/skin (jaundice).
3. Mood & Pregnancy Precautions
- Mood Monitoring: Patients recovering from alcohol or opioid dependence are at elevated risk for depression; report persistent low mood or suicidal thoughts promptly to your healthcare team.
- Pregnancy & Breastfeeding: Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding so individual risks and benefits can be carefully weighed.
Nalsign 50 Mg Australian Regulatory Context
- Australian TGA & PBS Context: In Australia, naltrexone hydrochloride 50 mg is classified as a Schedule 4 (Prescription Only) medicine under the TGA Poisons Standard and is listed on the Pharmaceutical Benefits Scheme (PBS Item 8370M under Streamlined Authority Code 13967 for alcohol dependence). Australian patients holding a valid signed written prescription from an Australian-registered medical practitioner can legally import up to a 3-month supply per shipment of Nalsign 50 Mg under the TGA Personal Importation Scheme.
Where Can I Buy Nalsign 50 Mg Online?
Eligible prescription holders can order genuine Nalsign 50 Mg Tablets (Naltrexone Hydrochloride IP 50 mg) securely through AustraliaRxMeds:
- Direct Online Ordering: Purchase factory-sealed 10-tablet blister strips via Australia with discreet, plain-packaged tracked shipping to Australia and worldwide destinations.
- TGA Personal Importation Compliance (Australia): Australian residents can legally order and import genuine Nalsign 50 Mg under the Therapeutic Goods Administration (TGA) Personal Importation Scheme provided that:
- You hold a valid signed written prescription issued by an Australian-registered medical practitioner (electronic eScripts cannot be verified at the Australian border for overseas personal imports).
- You import no more than a 3-month supply per single shipment at your prescribed daily dose.
- Your total imported volume across any 12-month period does not exceed a 15-month supply.
- The tablets remain in their original factory-sealed blister packaging and are strictly for personal medical treatment.
Authenticity & Quality Guarantee: AustraliaRxMeds supplies unadulterated, batch-verified pharmaceuticals produced under certified Good Manufacturing Practice (GMP) standards.
Medical References
- Therapeutic Goods Administration (TGA) / Australian Commission on Safety and Quality in Health Care. ARX-Naltrexone 50 mg Tablets & Naltrexone RBX (ARTG ID 504107): Consumer Medicine Information (CMI) & Schedule 4 Monograph.
- Pharmaceutical Benefits Scheme (PBS). Naltrexone Hydrochloride 50 mg Tablet (Item 8370M / Streamlined Authority Code 13967): Alcohol Dependence Prescribing Criteria.
- Alcohol and Drug Foundation (ADF Australia). Naltrexone Drug Facts: Clinical Uses, Opioid-Free Washout & Overdose Sensitivity Guidance.
- U.S. Food and Drug Administration (FDA). ReVia (naltrexone hydrochloride tablets, USP 50 mg): Full Prescribing Information, Precipitated Withdrawal, Hepatotoxicity & Post-Cessation Overdose Warnings.
FAQs
What is Nalsign 50 Mg used for?
Nalsign 50 Mg contains 50 mg of naltrexone hydrochloride and is used as part of a comprehensive recovery program to treat alcohol dependence (by reducing alcohol cravings and blocking the rewarding effects of drinking) and to prevent relapse in detoxified, formerly opioid-dependent adults.
Is Nalsign 50 addictive or habit-forming?
No. Nalsign 50 is a pure opioid receptor antagonist with zero narcotic or euphoric properties. It does not cause physical dependence, cannot be abused, and does not cause withdrawal symptoms when you stop taking it.
How long must I be opioid-free before starting Nalsign 50 Mg?
You must be completely free of all opioids for at least 7 to 10 days (and up to 10–14 days for long-acting opioids like methadone or buprenorphine) before taking your first Nalsign 50 mg tablet. Taking it sooner will trigger severe, sudden opioid withdrawal symptoms.
Will Nalsign 50 Mg make me sick if I drink alcohol?
No. Unlike disulfiram (Antabuse), Nalsign 50 Mg does not cause a violent physical sickness reaction if you drink alcohol. Instead, it blocks the endorphin "buzz" produced by alcohol, helping reduce cravings and preventing heavy drinking slips.
Can I take painkillers while on Nalsign 50 Mg?
You must avoid all opioid pain relievers (such as codeine, tramadol, oxycodone, or morphine) while taking Nalsign 50, because naltrexone blocks their pain-relieving effects. Non-opioid options like paracetamol or ibuprofen can usually be used if approved by your doctor.
Do I need a prescription to buy Nalsign 50 Mg in Australia?
Yes. In Australia, naltrexone 50 mg is a Schedule 4 prescription-only medicine. With a valid signed written prescription from an Australian-registered doctor, patients can legally import up to a 3-month supply per shipment via AustraliaRxMeds under the TGA Personal Importation Scheme.



